DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Shore ND, Saad F, Cookson MS. et al.
HERO Study Investigators. Oral relugolix for androgen-deprivation therapy in advanced prostate cancer.
N Engl J Med 2020;
382 (23) 2187-2196
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.